|
US8236A
(en)
|
|
1851-07-22 |
|
Hanging cakriage-body |
|
US319A
(en)
|
|
1837-07-31 |
|
Improvement in machines for breaking and dressing hemp and flax |
|
US4434150A
(en)
|
1981-10-19 |
1984-02-28 |
Ortho Diagnostic Systems, Inc. |
Immunological reagents employing polymeric backbone possessing reactive functional groups
|
|
US4486414A
(en)
|
1983-03-21 |
1984-12-04 |
Arizona Board Of Reagents |
Dolastatins A and B cell growth inhibitory substances
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US4880935A
(en)
|
1986-07-11 |
1989-11-14 |
Icrf (Patents) Limited |
Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates
|
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・２・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
US4936824A
(en)
|
1987-05-15 |
1990-06-26 |
The Boc Group, Inc. |
Infant incubator with air curtain
|
|
US4880078A
(en)
|
1987-06-29 |
1989-11-14 |
Honda Giken Kogyo Kabushiki Kaisha |
Exhaust muffler
|
|
US4816444A
(en)
|
1987-07-10 |
1989-03-28 |
Arizona Board Of Regents, Arizona State University |
Cell growth inhibitory substance
|
|
IL106992A
(en)
|
1988-02-11 |
1994-06-24 |
Bristol Myers Squibb Co |
Acylhydrazone derivatives of anthracycline and methods for their preparation
|
|
US5076973A
(en)
|
1988-10-24 |
1991-12-31 |
Arizona Board Of Regents |
Synthesis of dolastatin 3
|
|
EP0368684B2
(en)
|
1988-11-11 |
2004-09-29 |
Medical Research Council |
Cloning immunoglobulin variable domain sequences.
|
|
US4978744A
(en)
|
1989-01-27 |
1990-12-18 |
Arizona Board Of Regents |
Synthesis of dolastatin 10
|
|
JPH0684824B2
(ja)
|
1989-05-15 |
1994-10-26 |
清水建設株式会社 |
香り供給方法および香り供給装置
|
|
US4879278A
(en)
|
1989-05-16 |
1989-11-07 |
Arizona Board Of Regents |
Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
|
|
US4986988A
(en)
|
1989-05-18 |
1991-01-22 |
Arizona Board Of Regents |
Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5138036A
(en)
|
1989-11-13 |
1992-08-11 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Isolation and structural elucidation of the cytostatic cyclodepsipeptide dolastatin 14
|
|
US5124471A
(en)
|
1990-03-26 |
1992-06-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Bifunctional dtpa-type ligand
|
|
CA2109528A1
(en)
|
1991-05-01 |
1992-11-02 |
Gregory A. Prince |
A method for treating infectious respiratory diseases
|
|
US6287792B1
(en)
|
1991-06-17 |
2001-09-11 |
The Regents Of The University Of California |
Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology
|
|
US5622929A
(en)
|
1992-01-23 |
1997-04-22 |
Bristol-Myers Squibb Company |
Thioether conjugates
|
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
|
ZA932522B
(en)
|
1992-04-10 |
1993-12-20 |
Res Dev Foundation |
Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens
|
|
US6034065A
(en)
|
1992-12-03 |
2000-03-07 |
Arizona Board Of Regents |
Elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10
|
|
US5635483A
(en)
|
1992-12-03 |
1997-06-03 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Tumor inhibiting tetrapeptide bearing modified phenethyl amides
|
|
US5410024A
(en)
|
1993-01-21 |
1995-04-25 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide amides
|
|
US5780588A
(en)
|
1993-01-26 |
1998-07-14 |
Arizona Board Of Regents |
Elucidation and synthesis of selected pentapeptides
|
|
WO1994016729A1
(en)
|
1993-01-28 |
1994-08-04 |
Neorx Corporation |
Targeted nitric oxide pathway or nitric oxide synthase modulation
|
|
US5934272A
(en)
|
1993-01-29 |
1999-08-10 |
Aradigm Corporation |
Device and method of creating aerosolized mist of respiratory drug
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
WO1995015770A1
(en)
|
1993-12-09 |
1995-06-15 |
Neorx Corporation |
Pretargeting methods and compounds
|
|
US5530097A
(en)
|
1994-08-01 |
1996-06-25 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory peptide amides
|
|
US5521284A
(en)
|
1994-08-01 |
1996-05-28 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide amides and esters
|
|
US5504191A
(en)
|
1994-08-01 |
1996-04-02 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide methyl esters
|
|
US5554725A
(en)
|
1994-09-14 |
1996-09-10 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Synthesis of dolastatin 15
|
|
US5599902A
(en)
|
1994-11-10 |
1997-02-04 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Cancer inhibitory peptides
|
|
US5663149A
(en)
|
1994-12-13 |
1997-09-02 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
|
|
US6019968A
(en)
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
|
DK0871490T3
(da)
|
1995-12-22 |
2003-07-07 |
Bristol Myers Squibb Co |
Forgrenede hydrazonlinkere
|
|
IT1282692B1
(it)
|
1996-02-27 |
1998-03-31 |
San Raffaele Centro Fond |
Citochine modificate per l'uso in terapia
|
|
ATE508733T1
(de)
|
1996-03-04 |
2011-05-15 |
Penn State Res Found |
Materialien und verfahren zur steigerung der zellulären internalisierung
|
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
US5985309A
(en)
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
CA2277801C
(en)
|
1997-01-16 |
2002-10-15 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
|
JP2001511811A
(ja)
|
1997-02-13 |
2001-08-14 |
ボーン ケア インターナショナル インコーポレイテッド |
ビタミンｄ化合物の標的治療放出
|
|
WO1998036765A1
(en)
|
1997-02-25 |
1998-08-27 |
Arizona Board Of Regents |
Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18
|
|
JPH11154024A
(ja)
|
1997-09-16 |
1999-06-08 |
Sumitomo Electric Ind Ltd |
負荷液圧の制御方法
|
|
US6555367B1
(en)
|
1997-10-10 |
2003-04-29 |
The United States Of America As Represented By The Department Of Health And Human Services |
Complex of biotinylated viral vector and ligand for targeted gene delivery
|
|
US6280955B1
(en)
|
1997-12-16 |
2001-08-28 |
Tularik Inc. |
Interleukin-1 receptor accessory proteins, nucleic acids and methods
|
|
DK1071700T3
(da)
|
1998-04-20 |
2010-06-07 |
Glycart Biotechnology Ag |
Glykosylerings-modifikation af antistoffer til forbedring af antistofafhængig cellulær cytotoksicitet
|
|
WO1999066903A2
(en)
|
1998-06-24 |
1999-12-29 |
Advanced Inhalation Research, Inc. |
Large porous particles emitted from an inhaler
|
|
CA2704600C
(en)
|
1999-04-09 |
2016-10-25 |
Kyowa Kirin Co., Ltd. |
A method for producing antibodies with increased adcc activity
|
|
CN1269087C
(zh)
|
1999-07-31 |
2006-08-09 |
朴奎珍 |
使用数字音频和字幕数据的学习方法和装置
|
|
US6323315B1
(en)
|
1999-09-10 |
2001-11-27 |
Basf Aktiengesellschaft |
Dolastatin peptides
|
|
WO2001090198A1
(en)
|
2000-05-24 |
2001-11-29 |
Ludwig Institute For Cancer Research |
Multicomponent conjugates which bind to target molecules and stimulate cell lysis
|
|
ES2252261T3
(es)
|
2000-06-28 |
2006-05-16 |
Glycofi, Inc. |
Metodos para producir glicoproteinas modificadas.
|
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
|
AU2013203432A1
(en)
|
2000-06-29 |
2013-05-02 |
Abbvie Inc. |
Dual specificity antibodies and methods of making and using
|
|
US20030026806A1
(en)
|
2000-10-27 |
2003-02-06 |
Amgen Inc. |
Antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
US20030083263A1
(en)
|
2001-04-30 |
2003-05-01 |
Svetlana Doronina |
Pentapeptide compounds and uses related thereto
|
|
US6441163B1
(en)
|
2001-05-31 |
2002-08-27 |
Immunogen, Inc. |
Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
|
|
US20030138803A1
(en)
|
2001-07-27 |
2003-07-24 |
Brooksbank Robert Alan |
Identification and use of molecules implicated in pain
|
|
US20030049255A1
(en)
|
2001-08-07 |
2003-03-13 |
Sims John E. |
Interleukin-1 receptors in the treatment of diseases
|
|
CA2451998A1
(en)
|
2001-08-17 |
2003-02-27 |
Eli Lilly And Company |
Anti-a.beta. antibodies
|
|
CA2463879C
(en)
|
2001-10-25 |
2012-12-04 |
Genentech, Inc. |
Glycoprotein compositions
|
|
CA2482967A1
(en)
|
2002-05-01 |
2003-11-13 |
Trellis Bioscience, Inc. |
Binary or polynary targeting and uses thereof
|
|
DK1545613T3
(da)
|
2002-07-31 |
2011-11-14 |
Seattle Genetics Inc |
Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom
|
|
DE60336149D1
(de)
|
2002-08-16 |
2011-04-07 |
Immunogen Inc |
Vernetzer mit hoher reaktivität und löslichkeit und ihre verwendung bei der herstellung von konjugaten für die gezielte abgabe von kleinmolekularen arzneimitteln
|
|
KR101317045B1
(ko)
|
2002-09-06 |
2013-10-16 |
암젠 인코포레이티드 |
치료학적 인체 항-ｉｌ-1ｒ1 모노클로날 항체
|
|
US7388079B2
(en)
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
|
AR045614A1
(es)
|
2003-09-10 |
2005-11-02 |
Hoffmann La Roche |
Anticuerpos contra el recepctor de la interleuquina- 1 y los usos de los mismos
|
|
US20050129685A1
(en)
|
2003-09-18 |
2005-06-16 |
Jingtai Cao |
Use of IL-1 blockers to prevent corneal inflammation and neovascularization
|
|
EP2478912B1
(en)
|
2003-11-06 |
2016-08-31 |
Seattle Genetics, Inc. |
Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy
|
|
EP1718323B1
(en)
|
2004-02-20 |
2011-12-07 |
The Trustees of The University of Pennsylvania |
Binding peptidomimetics and uses of the same
|
|
US20050226882A1
(en)
|
2004-04-08 |
2005-10-13 |
Awdalla Essam T |
Method and multicomponent conjugates for treating cancer
|
|
AU2005233387B2
(en)
|
2004-04-15 |
2011-05-26 |
Glycofi, Inc. |
Production of galactosylated glycoproteins in lower eukaryotes
|
|
US8618054B2
(en)
|
2004-05-05 |
2013-12-31 |
Valorisation-Rechereche Société en Commandite |
Interleukin-1 receptor antagonists, compositions, and methods of treatment
|
|
EP1751175B1
(en)
|
2004-05-05 |
2012-07-25 |
VALORISATION-RECHERCHE, Société en Commandite |
Interleukin-1 receptor antagonists, compositions, and methods of treatment
|
|
US7691962B2
(en)
|
2004-05-19 |
2010-04-06 |
Medarex, Inc. |
Chemical linkers and conjugates thereof
|
|
NZ579482A
(en)
|
2004-06-01 |
2011-02-25 |
Genentech Inc |
Antibody drug conjugates and methods
|
|
GB0419124D0
(en)
*
|
2004-08-27 |
2004-09-29 |
Proteome Sciences Plc |
Methods and compositions relating to Alzheimer's disease
|
|
EP1695717A1
(en)
|
2005-02-23 |
2006-08-30 |
Ludwig-Maximilians-Universität |
Transport of nano-and macromolecular structures into cytoplasm and nucleus of cells
|
|
AU2014203217B2
(en)
|
2005-08-19 |
2017-03-30 |
Abbvie Inc. |
Dual variable domain immunoglobin and uses thereof
|
|
WO2007047969A2
(en)
|
2005-10-21 |
2007-04-26 |
Amgen Inc. |
Methods of decreasing vascular calcification using il-1 inhibitors
|
|
WO2007096398A1
(en)
|
2006-02-22 |
2007-08-30 |
University Of Zurich |
Soluble receptors and methods for treating autoimmune or demyelinating diseases
|
|
CA2690973A1
(en)
|
2006-06-23 |
2007-12-27 |
Paul M. Simon |
Targeted immune conjugates
|
|
US7560530B1
(en)
|
2006-07-20 |
2009-07-14 |
Schering Corporation |
IL-33 receptor
|
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
|
US7767206B2
(en)
*
|
2006-10-02 |
2010-08-03 |
Amgen Inc. |
Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
|
|
US7632490B2
(en)
|
2006-10-20 |
2009-12-15 |
Regeneron Pharmaceuticals, Inc. |
Use of IL-1 antagonists to treat gout
|
|
US7598028B2
(en)
|
2006-11-28 |
2009-10-06 |
The Regents Of The University Of Michigan |
Compositions and methods for detecting and treating prostate disorders
|
|
EP2112942A2
(en)
|
2007-01-03 |
2009-11-04 |
The Regents of the University of California |
An apparatus and method for in vivo intracellular transfection of gene, sirna, shrna vectors, and other biomedical diagnostic and therapeutic drugs and molecules for the treatment of arthritis and other orthopedic diseaseas in large animals and humans
|
|
KR20090114430A
(ko)
|
2007-02-02 |
2009-11-03 |
베일러 리서치 인스티튜트 |
항원-제시 세포 상에서 발현된 ｄｃｉｒ에 대한 항원 표적화에 기초한 백신
|
|
TWI422594B
(zh)
|
2007-02-02 |
2014-01-11 |
Baylor Res Inst |
經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
|
|
KR101598229B1
(ko)
|
2007-02-16 |
2016-02-26 |
메리맥 파마슈티컬즈, 인크. |
Ｅｒｂｂ3에 대한 항체 및 이의 용도
|
|
NZ595319A
(en)
|
2007-02-23 |
2012-09-28 |
Baylor Res Inst |
Activation of human antigen-presenting cells through clec-6
|
|
EP2132226B1
(en)
|
2007-02-23 |
2019-03-27 |
Baylor Research Institute |
Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized ldl receptor-1 (lox-1)
|
|
US20110159018A1
(en)
|
2007-05-03 |
2011-06-30 |
Medizinische Universitat Innsbruck |
Complement factor h-derived short consensus repeat-antibody constructs
|
|
EP2187900B1
(en)
|
2007-08-16 |
2016-11-09 |
The Schepens Eye Research Institute, Inc. |
Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues
|
|
WO2009120905A2
(en)
|
2008-03-26 |
2009-10-01 |
Cellerant Therapeutics, Inc. |
Immunoglobulin and/or toll-like receptor proteins associated with myelogenous haematological proliferative disorders and uses thereof
|
|
CN101348526B
(zh)
*
|
2008-08-29 |
2011-08-17 |
浙江大学 |
一种抗白细胞介素-8抗体
|
|
US8298533B2
(en)
|
2008-11-07 |
2012-10-30 |
Medimmune Limited |
Antibodies to IL-1R1
|
|
US10117906B2
(en)
|
2009-01-09 |
2018-11-06 |
The Schepens Eye Research Institute, Inc. |
Methods for reducing corneal nerves damage, corneal lymphangiogenesis or immunity to corneal antigens in dry-eye associated ocular surface diseases by IL-1Ra
|
|
EP2391891A1
(en)
|
2009-01-27 |
2011-12-07 |
Proteogenix, Inc. |
Biomarkers for detection of neonatal sepsis in biological fluid
|
|
EP2411413B1
(en)
|
2009-03-23 |
2016-05-11 |
Quark Pharmaceuticals, Inc. |
Compounds compositions and methods of treating cancer and fibrotic diseases
|
|
CN102460162A
(zh)
|
2009-05-01 |
2012-05-16 |
俄勒冈健康科学大学 |
体内扩增人肝细胞的方法
|
|
DE102009026075A1
(de)
|
2009-06-30 |
2011-01-05 |
Röhm Gmbh |
Bohrvorrichtung
|
|
WO2011017294A1
(en)
|
2009-08-07 |
2011-02-10 |
Schering Corporation |
Human anti-rankl antibodies
|
|
GB2472856B
(en)
|
2009-08-21 |
2012-07-11 |
Cantargia Ab |
IL1-RAP modulators and uses thereof
|
|
EP2475388B1
(en)
|
2009-09-10 |
2017-11-08 |
Merck Sharp & Dohme Corp. |
Use of il-33 antagonists to treat fibrotic disease
|
|
EP2478013B1
(en)
|
2009-09-16 |
2018-10-24 |
F.Hoffmann-La Roche Ag |
Coiled coil and/or tether containing protein complexes and uses thereof
|
|
US20110076232A1
(en)
|
2009-09-29 |
2011-03-31 |
Ludwig Institute For Cancer Research |
Specific binding proteins and uses thereof
|
|
WO2011057216A1
(en)
|
2009-11-06 |
2011-05-12 |
The Pennsylvania State Research Foundation |
Bioconjugation of calcium phosphosilicate nanoparticles for selective targeting of cells in vivo
|
|
GB0919751D0
(en)
|
2009-11-11 |
2009-12-30 |
King S College Hospital Nhs Fo |
Conjugate molecule
|
|
US20130195868A1
(en)
|
2010-06-24 |
2013-08-01 |
Eleven Biotherapeutics, Inc. |
Treating surface of the eye disorders
|
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
|
UY33826A
(es)
|
2010-12-22 |
2012-07-31 |
Abbott Lab |
Proteínas de unión con dominios trivariables y sus usos
|
|
US20120201746A1
(en)
|
2010-12-22 |
2012-08-09 |
Abbott Laboratories |
Half immunoglobulin binding proteins and uses thereof
|
|
US9403906B2
(en)
|
2011-01-19 |
2016-08-02 |
Cantargia Ab |
Method of treatment of a solid tumor with interleukin-1 accessory protein antibody
|
|
US20140030735A1
(en)
|
2011-03-07 |
2014-01-30 |
Temple University - Of The Commonwealth System Of Higher Education |
Biomarkers of chronic obstructive pulmonary disease
|
|
EP2697260A1
(en)
|
2011-04-15 |
2014-02-19 |
Merck Patent GmbH |
Anti- il-1r1 inhibitors for use in cancer
|
|
JP6072771B2
(ja)
|
2011-04-20 |
2017-02-01 |
メディミューン，エルエルシー |
Ｂ７−ｈ１およびｐｄ−１に結合する抗体およびその他の分子
|
|
CA2837651A1
(en)
|
2011-06-21 |
2012-12-27 |
Oncofactor Corporation |
Compositions and methods for the therapy and diagnosis of cancer
|
|
US9873918B2
(en)
|
2011-08-11 |
2018-01-23 |
Albert Einstein College Of Medicine, Inc. |
Treatment of acute myeloid leukemia and myelodysplastic syndromes
|
|
US9534058B2
(en)
|
2012-02-08 |
2017-01-03 |
Abbvie Stemcentrx Llc |
Anti-CD324 monoclonal antibodies and uses thereof
|
|
AR091023A1
(es)
|
2012-05-11 |
2014-12-30 |
Abbvie Inc |
Inhibidores del nampt
|
|
WO2014100772A1
(en)
|
2012-12-21 |
2014-06-26 |
Cellerant Therapeutics, Inc. |
Antibodies that bind membrane-bound il1rap
|
|
WO2014135655A1
(en)
|
2013-03-06 |
2014-09-12 |
Institut Curie |
Compositions and methods for treating muscle-invasive bladder cancer
|
|
JO3532B1
(ar)
|
2013-03-13 |
2020-07-05 |
Regeneron Pharma |
الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها
|
|
US10118971B2
(en)
|
2013-03-13 |
2018-11-06 |
Ibentrus, Inc. |
Protein in which electrical interaction is introduced within hydrophobic interaction site and preparation method therefor
|
|
EP2968454B1
(en)
|
2013-03-15 |
2019-02-13 |
Regeneron Pharmaceuticals, Inc. |
Il-33 antagonists and uses thereof
|
|
WO2014144292A2
(en)
*
|
2013-03-15 |
2014-09-18 |
Sanofi Pasteur Biologics , Llc |
Antibodies against clostridium difficile toxins and methods of using the same
|
|
AR095196A1
(es)
|
2013-03-15 |
2015-09-30 |
Regeneron Pharma |
Medio de cultivo celular libre de suero
|
|
WO2014194166A1
(en)
|
2013-05-31 |
2014-12-04 |
Regeneron Pharmaceuticals, Inc. |
Methods of using il-1 antagonists to treat alzheimer's disease
|
|
BR112016001128A2
(pt)
|
2013-07-19 |
2018-01-23 |
Vib Vzw |
membros da família il-1 modificados direcionados
|
|
GB201403875D0
(en)
|
2014-03-05 |
2014-04-16 |
Cantargia Ab |
Novel antibodies and uses thereof
|
|
NO2785538T3
(https=)
|
2014-05-07 |
2018-08-04 |
|
|
|
US20170218091A1
(en)
|
2014-07-03 |
2017-08-03 |
Abbvie Inc. |
Monovalent binding proteins
|
|
GB201413913D0
(en)
|
2014-08-06 |
2014-09-17 |
Cantargia Ab |
Novel antibodies and uses thereof
|
|
EP3183582B1
(en)
|
2014-08-18 |
2020-02-12 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Biomarkers for diagnosis and management of neuro-immunological diseases
|
|
JP2016044126A
(ja)
|
2014-08-19 |
2016-04-04 |
国立大学法人埼玉大学 |
次世代型フラグメント抗体作製用ｄｎａライブラリの作製方法、その方法を用いて作製されたライブラリ、及び次世代型フラグメント抗体
|
|
JP7231326B2
(ja)
|
2014-11-10 |
2023-03-01 |
ジェネンテック， インコーポレイテッド |
Ｉｌ－３３媒介性障害のための治療及び診断方法
|
|
CR20170240A
(es)
|
2014-11-10 |
2018-04-03 |
Genentech Inc |
Anticuerpos anti-interleucina-33 y sus usos
|
|
JP6787888B2
(ja)
|
2014-11-10 |
2020-11-18 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
抗ｉｌ−１ベータ抗体及び使用方法
|
|
PT3221356T
(pt)
|
2014-11-20 |
2020-10-29 |
Hoffmann La Roche |
Moléculas de ligação ao antigénio biespecíficas ativadoras das células t contra folr1 e cd3
|
|
WO2016085832A1
(en)
|
2014-11-24 |
2016-06-02 |
Albert Einstein College Of Medicine, Inc. |
Peptides for blocking il1rap protein-protein interaction and uses thereof for treatment of disease
|
|
JP6519913B2
(ja)
|
2015-02-05 |
2019-05-29 |
国立大学法人名古屋大学 |
ＩｇＥ結合性エピトープペプチドの利用
|
|
US9504694B2
(en)
|
2015-03-19 |
2016-11-29 |
Cellerant Therapeutics, Inc. |
Isoquinolidinobenzodiazepines
|
|
TWI735433B
(zh)
|
2015-03-27 |
2021-08-11 |
美商再生元醫藥公司 |
偵測生物污染物之組成物及方法
|
|
HRP20210096T1
(hr)
|
2015-03-31 |
2021-03-05 |
Medimmune Limited |
Novi oblik il33, mutirani oblici il33, protutijela, testovi i postupci njegove upotrebe
|
|
WO2016179319A1
(en)
|
2015-05-04 |
2016-11-10 |
Cellerant Therapeutics, Inc. |
Chimeric antigen receptors with ctla4 signal transduction domains
|
|
RU2017142394A
(ru)
|
2015-05-08 |
2019-06-10 |
Президент Энд Феллоус Оф Гарвард Колледж |
Целевой отбор пациентов для лечения производными кортистатина
|
|
JP7114460B2
(ja)
|
2015-06-26 |
2022-08-08 |
サノフィ・バイオテクノロジー |
モノクローナル抗ＩＬ－１ＲＡｃＰ抗体
|
|
WO2017011803A1
(en)
|
2015-07-16 |
2017-01-19 |
Cellerant Therapeutics, Inc. |
Cysteine-substituted immunoglobulins
|
|
TWI717375B
(zh)
|
2015-07-31 |
2021-02-01 |
德商安美基研究（慕尼黑）公司 |
Ｃｄ７０及ｃｄ３抗體構築體
|
|
TWI870789B
(zh)
|
2015-08-04 |
2025-01-21 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法
|
|
EA201890891A1
(ru)
|
2015-10-06 |
2018-09-28 |
Ридженерон Фармасьютикалз, Инк. |
Биомаркеры, связанные с заболеваниями, опосредованными интерлейкином-33 (ил-33), и их применение
|
|
EA201891084A1
(ru)
|
2015-11-02 |
2019-10-31 |
|
Антитела к il1rap, биспецифические антигенсвязывающие молекулы, которые связываются с il1rap и cd3, и их применение
|
|
HK1258375A1
(zh)
|
2015-11-24 |
2019-11-08 |
Onk Therapeutics Limited |
人源化抗-cll-1抗体
|
|
WO2017112823A1
(en)
|
2015-12-23 |
2017-06-29 |
President And Fellows Of Harvard College |
Targeted selection of patients for treatment with specific cortistatin derivatives
|
|
MX2018013038A
(es)
|
2016-04-27 |
2019-03-28 |
Pfizer |
Anticuerpos anti-il-33, composiciones, metodos y usos de los mismos.
|
|
EP3241845A1
(en)
|
2016-05-06 |
2017-11-08 |
MAB Discovery GmbH |
Humanized anti-il-1r3 antibodies
|
|
CN106831998B
(zh)
|
2016-06-22 |
2020-09-15 |
徐州医科大学 |
一种人il1rap特异性car及其应用
|
|
JP6848241B2
(ja)
|
2016-07-25 |
2021-03-24 |
東ソー株式会社 |
Ｆｃ結合性タンパク質を用いたＩｇＧ１の精製方法
|
|
EP3570865A4
(en)
|
2016-09-02 |
2020-05-20 |
180 Therapeutics LP |
METHOD FOR TREATING A LOCALIZED FIBROTIC DISEASE USING A BISPECIFIC IL-33 / TNF ANTIBODY
|
|
WO2018053552A2
(en)
|
2016-09-19 |
2018-03-22 |
Cellerant Therapeutics, Inc. |
Isoquinolidinobenzodiazepines
|
|
JP2019530707A
(ja)
|
2016-10-10 |
2019-10-24 |
セレラント セラピューティクス インコーポレイテッド |
イソキノリジノベンゾジアゼピン（ｉｑｂ）−１（クロロメチル）−２，３−ジヒドロ−１ｈ−ベンゾ［ｅ］インドール（ｃｂｉ）二量体
|
|
US10222376B2
(en)
|
2016-11-03 |
2019-03-05 |
The Charlotte-Mecklenburg Hospital Authority |
Methods and compositions for identifying leukemic stem cells
|
|
TWI784988B
(zh)
|
2016-12-01 |
2022-12-01 |
美商再生元醫藥公司 |
治療發炎症狀的方法
|
|
CA3046093A1
(en)
|
2016-12-14 |
2018-06-21 |
Progenity Inc. |
Treatment of a disease of the gastrointestinal tract with an il-1 inhibitor
|
|
WO2018112441A1
(en)
|
2016-12-15 |
2018-06-21 |
Progenity Inc. |
Ingestible device and associated methods
|
|
JP6995127B2
(ja)
|
2017-02-10 |
2022-02-04 |
ジェネンテック， インコーポレイテッド |
抗トリプターゼ抗体、その組成物、及びその使用
|
|
MX2019012171A
(es)
|
2017-04-13 |
2019-11-25 |
Regeneron Pharma |
Tratamiento e inhibicion de enfermedades pulmonares inflamatorias en pacientes que tienen alelos de riesgo en los genes que codifican la il33 e il1rl1.
|
|
EP3401332A1
(en)
|
2017-05-08 |
2018-11-14 |
MAB Discovery GmbH |
Anti-il-1r3 antibodies for use in inflammatory conditions
|
|
KR102116178B1
(ko)
|
2017-05-10 |
2020-05-27 |
서울대학교산학협력단 |
간암 고위험군의 간암 발병 모니터링 또는 진단용 바이오마커 및 그 용도
|
|
KR20200014379A
(ko)
|
2017-06-05 |
2020-02-10 |
얀센 바이오테크 인코포레이티드 |
비대칭 ch2-ch3 영역 돌연변이를 갖는 조작된 다중특이성 항체 및 다른 다량체 단백질
|
|
CA3066918A1
(en)
|
2017-06-12 |
2018-12-20 |
Bluefin Biomedicine, Inc. |
Anti-il1rap antibodies and antibody drug conjugates
|
|
BR112020000127A2
(pt)
|
2017-07-06 |
2020-07-07 |
Regeneron Pharmaceuticals, Inc. |
método para selecionar um hidrolisado de soja, e, glicoproteína
|
|
WO2019024979A1
(en)
|
2017-07-31 |
2019-02-07 |
Institute For Research In Biomedicine |
FUNCTIONAL DOMAIN ANTIBODIES IN THE ELBOW REGION
|
|
AU2018312563A1
(en)
|
2017-08-01 |
2020-03-12 |
City Of Hope |
Anti-IL1RAP antibodies
|
|
WO2019060869A1
(en)
|
2017-09-25 |
2019-03-28 |
Discitisdx, Inc. |
METHODS FOR TREATING DEGENERATIVE DISC DISEASE AND CHRONIC LOMBALGIA
|
|
AU2018370217A1
(en)
|
2017-11-17 |
2020-05-28 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for alleviating Cytokine Release Syndrome
|
|
EP3489259A1
(en)
|
2017-11-23 |
2019-05-29 |
Etablissement Français du Sang |
Anti-il-1rap-car-t cells and their use
|
|
GB201720077D0
(en)
|
2017-12-01 |
2018-01-17 |
Univ Oxford Innovation Ltd |
Leukaemic stem cell
|
|
GB201800649D0
(en)
|
2018-01-16 |
2018-02-28 |
Argenx Bvba |
CD70 Combination Therapy
|
|
KR20220098056A
(ko)
|
2018-02-09 |
2022-07-08 |
제넨테크, 인크. |
비만 세포 매개 염증성 질환에 대한 치료 및 진단 방법
|
|
GB201802307D0
(en)
|
2018-02-13 |
2018-03-28 |
Vib Vzw |
CD36 antagonists for use in melanoma treatment
|
|
EP3752200A1
(en)
|
2018-02-13 |
2020-12-23 |
Vib Vzw |
Targeting minimal residual disease in cancer with rxr antagonists
|
|
CA3101271A1
(en)
|
2018-05-24 |
2019-11-28 |
Janssen Biotech, Inc. |
Anti-cd3 antibodies and uses thereof
|
|
JP7428661B2
(ja)
|
2018-05-30 |
2024-02-06 |
中外製薬株式会社 |
Ｉｌ－１ｒ１結合ドメインおよび運搬部分を含むポリペプチド
|
|
KR20190140756A
(ko)
|
2018-06-12 |
2019-12-20 |
주식회사 노보셀바이오 |
자연 살상 세포에 결합하는 이중특이적 항체 및 이의 용도
|